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User-centered designPurpose: Older adults are at increased risk of adverse drug events due to medication. Older adults tend to
take more medication and are at higher risk of chronic illness. Over-the-counter (OTC) medication does
not require healthcare provider oversight and understanding OTC information is heavily dependent on a
consumer’s ability to understand and use the medication appropriately. Coupling health technology with
effective communication is one approach to address the challenge of communicating health and improv-
ing health related tasks. However, the success of many health technologies also depends on how well the
technology is designed and how well it addresses users needs. This is especially true for the older adult
population. This paper describes (1) a formative study performed to understand how to design novel
health technology to assist older adults with OTC medication information, and (2) how a user-centered
design process helped to reﬁne the initial assumptions of user needs and help to conceptualize the tech-
nology.
Methods: An iterative design process was used. The process included two brainstorming and review ses-
sions with human–computer interaction researchers and design sessions with older adults in the form of
semi-structured interviews. Methods and principles of user-centered research and design were used to
inform the research design. Two researchers with expertise in human–computer interaction performed
expert reviews of early system prototypes. After initial prototypes were developed, seven older adults
were engaged in semi-structured interviews to understand usability concerns and features and function-
ality older adults may ﬁnd useful for selecting appropriate OTC medication.
Results: Eight usability concerns were discovered and addressed in the two rounds of expert review, and
nine additional usability concerns were discovered in design sessions with older adults. Five themes
emerged from the interview transcripts as recommendations for design. These recommendations repre-
sent opportunities for technology such as the one described in this paper to support older adults in the
OTC decision-making process.
Discussion: This paper illustrates the use of an iterative user-centered process in the formative stages of
design and its usefulness for understanding aspects of the technology design that are useful to older
adults when making decisions about OTC medication. The technology support mechanisms included in
the initial model were revised based on the results from the iterative design sessions and helped to reﬁne
and conceptualize the system being designed.
 2015 Elsevier Inc. All rights reserved.1. Introduction
In the healthcare community, understanding how to communi-
cate different types of health information to different individuals
and groups is a sizable concern [4,32]. Some health-related tasks,such as choosing an appropriate over-the-counter (OTC) medica-
tion, do not require direct oversight from a healthcare provider
and place the decision-making task in the hands of consumers
[1,9,11]. There are nearly one hundred thousand OTC medications
available and like prescription medication, safe OTC medication
use is heavily dependent on a consumer’s ability to understand
and use the medication appropriately [34]. However, OTC
medication is somewhat different because it does not require a
doctor’s approval and places more of the decision-making task
on the consumer [1]. Thousands of hospitalizations and fatalities
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ication [1,24,11,17]. However, consumers often view OTC medica-
tion differently than prescription medication and generally
perceive them as less of a risk [11]. When reading OTC medication
instructions consumers may often misunderstand the information,
which further contributes to the large number of adverse drug
events occurring each year [1,11,17]. Therefore, consumers need
sufﬁcient health-related knowledge to lessen their risk of poten-
tially fatal events due to medication.
Older adults are particularly at a higher risk for ADEs due to fac-
tors related to aging [1]. In a 2014 article reporting the ﬁndings of
the Consumer Health Products Association – Gerontological
Society of America (CHPA–GSA) National Summit, Albert et al.
reviewed published research related to OTC medication behaviors
among older adults and called for more research to ﬁll the gaps
in knowledge in this area [1]. The report noted that while older
adults (65 years and older) account for only 13% of the United
States population, they account for 30% of OTC medication use. In
addition, older adults tend to be at a higher risk of chronic illness
and are more likely to take more medication increasing their risk
of ADEs [24,1]. Older adults also tend to have lower health literacy
levels, which also contribute to a higher risk of adverse drug events
[1,32,20].
1.1. Background
Health literacy or the ‘‘degree to which an individual has the
capacity to obtain, process, and understand basic health informa-
tion and services needed to make appropriate health decisions’’
is noted throughout literature as a contributing factor to the suc-
cess of health communication efforts [4,32,45]. Adequate health
literacy is also central to favorable health outcomes [32,45].
According to the most recent report of Health Literacy in the
United Stated, adults 65 years of age and older tend to have on
average lower health literacy levels than adults younger than
65 years [20]. Many factors affect a person’s ability to understand
health information including how the information is presented
[4,32]. For older adults, one of the primary challenges with OTC
medication is the size of the font used on the labels [26,46,48].
However, formatting, information order, external tag placement,
and language used may also inﬂuence how well OTC medication
labels communicate information to consumers [19,28,34,46,48].
The Food and Drug Administration has implemented considerable
guidelines for ensuring that the OTC medication label is designed
to be ‘‘easy-to-read’’ however, ADEs still occur [43]. Health infor-
mation technology (HIT) is a promising approach for addressing
the challenges of communicating health information [1,14]. HIT
focuses on how technology can be used to assist consumers, prac-
titioners, and other stakeholders with health-related tasks.
However, the effectiveness of HIT often depends on the usability
of the technology.
Usability is an important factor in the adoption of HIT by users.
The goals of usability are to ensure that technologies are effective,
efﬁcient, safe, have good utility, are easy to learn, and easy to
remember [36]. User-centered design (UCD) is one way to improve
usability and can be useful to begin to explore how technology
may or may not be of beneﬁt to a target user group. For example,
UCD can provide designers with an understanding of the users’
current practices so that they can begin to identify tasks that are
important, areas where technology can provide beneﬁt, or oppor-
tunities and challenges of technology integration. Once designers
have a sense of the current practices, they can also begin to brain-
storm appropriate technological solutions and explore features and
functionality that may be useful to include in the technology.
Understanding users throughout the design cycle can impact the
perceived beneﬁt of the resultant technology thereby increasingthe chances of adoption and long-term use by a group of users.
The beneﬁt of the technology is of special importance among the
older adult population [27]. Within HIT, understanding the
intended users, the tasks to be performed, and the environment
in which the technology is to be deployed are essential for utiliza-
tion [50]. Usability evaluation is therefore recognized as an impor-
tant step in HIT evaluation and is recommended throughout the
HIT development lifecycle [50,21].
The importance of usability in HIT adoption has led to a growth
in research at the cross-section of HIT and Human–Computer
Interaction (HCI). HCI researchers focus on the interaction between
people and computers and how to improve those interactions.
Therefore, improving or providing usability is often a goal of HCI
studies. Research at the intersection of HCI and HIT has addressed
several of the healthcare concerns surrounding patient or
consumer-based medication practices. Several researchers have
used HCI techniques to design medication adherence and manage-
ment systems to remind patients to take medication and of correct
dosage [7,8,15,18,37–41,44,2,3,49,12,22]. Other researchers have
focused on how to design systems to keep patients informed about
their medication and treatment during or after their hospital stay
[47,6,7]. Another group of researchers has focused on designing
patient education systems that could be used by nurses to help
patients understand potential drug interactions with alcohol
[29,30,31].
In each of these cases, users from the targeted user group were
included at varying phases in the design process. Many of these
applications were designed from a patient’s perspective with the
goal of improving usability and thereby promoting use. By doing
so results suggest that the researchers were able to (1) understand
current challenges (2) identify opportunities for technology design
to help or (3) identify design issues that might impede the use of
the technology. The design implications or considerations identi-
ﬁed in the research could then be used to improve the current sys-
tem or inform the design of a future system.
As noted, much of the literature dedicated to the design of med-
ication related technology has focused on medication management
or adherence. Managing a medication regimen can be a complex
task especially for older adults [25,39]. At a high-level, medication
management can include any tasks related to buying, taking, and
understanding various medication [25]. However, each task pre-
sents its own set of challenges. Oftentimes medication manage-
ment applications are designed to meet one or all of the tasks
related to medication management. For example, medication
adherence systems typically focus on monitoring whether or not
a patient has taken a medication or whether or not a medication
was taken on time. Other systems may focus on helping patients
schedule medication or reﬁlls to help them adhere to a particular
regimen. However, little guidance is available on how to design
medication management applications that focus on helping con-
sumers to make a decision about a medication, which is a some-
what different task.
Understanding the decision-making process has been cited as a
key area for understanding OTC behaviors among older adults
[1,26]. Consumer decision-making is concerned with ‘‘how con-
sumers develop and use strategies for making decisions, how dif-
ferent amounts of prior knowledge inﬂuence consumer choice
processes, how consumers adapt to different decision strategies,
and how consumers categorize products’’ [5]. Bettman and col-
leagues [5] describe a consumer decision-making task as an intri-
cate set of factors that requires a consumer to consider the
number of alternatives available, attributes of value, uncertainty,
availability of information in terms of environment and content,
and a variety of other factors (e.g. importance of the task – what
are the consequences of making the wrong decision). In the case
of OTC decision-making, there are thousands of OTC medications
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attributes of values (risks, warnings, dosages, or ingredients) that
present tradeoffs. In the pharmacy (environment), the label
provides one source of information. The pharmacist is also a good
information source in the pharmacy. The content provided by the
label and the pharmacist can also provide consumers with addi-
tional information about tradeoffs of attribute values (e.g. risks,
warnings). However, oftentimes these sources are underutilized
due to other factors. For example, the small print on the label is
noted as a recurring challenge for OTC consumers, especially the
older adult population [19,26,45]. Understanding health terminol-
ogy can also be challenging and may impact how consumers are
able to comprehend the OTC medication label [32,26]. Because of
the challenges of the OTC consumer-decision making process, the
task can become complex.
This research extends previous research on the design of
consumer-focused or patient-focused medication applications by
exploring the design of a novel OTC consumer-decision making
tool to assist older adults. To the authors’ knowledge, no prior work
currently exists that focuses speciﬁcally on understanding how to
design technology to assist older adults with consumer
decision-making while in the process of selecting OTC medication.
This paper describes the iterative design process employed to con-
ceptualize and design a novel interface to assist older adults with
the task of selecting appropriate OTC medication. Further, this
paper describes the evaluation of the interface with older adults
and their opinions of how technology could support them in the
OTC consumer decision-making task.2. Methods
This phase of research is part of a larger Exploratory-Sequential
Mixed Method study [10] and each phase of the study was used to
inform the next phase. Prior work included a formative study that
focused on understanding the OTC decision-making practices of
older adults [26]. Results from the prior study were used in the
current study to inform the design of an initial prototype that
was used in review sessions with HCI researchers and as a probe
in sessions with older adults. For the current study, an iterative
design process was employed to help conceptualize the technology
and reﬁne the design of the preliminary prototypes and to better
understand the role of technology in facilitating the OTC consumer
decision-making process.
2.1. Prior work
A formative study was conducted previously to identify chal-
lenges and barriers to selecting appropriate OTC medication for
older adults [26]. The formative study included semi-structured
interviewswith older adults (n = 10) that focused on understanding
older adults’ current OTC decision-making practices and identifying
challenges and barriers toOTCmedication information. Older adults
in this study discussed their current OTCmedication practices, their
process of deciding which OTC medication to take given their prior
health history, the people and information sources involved in that
process, and any barriers or challenges they faced when selecting
appropriate OTC medication. From this study, the researchers iden-
tiﬁed an initial set of challenges and barriers to OTC medication
information for older adults and created a preliminary model of
the OTC decision-making process for older adults [26].
2.2. Study overview
Results of prior work, prior literature on design for older adults,
and prior literature on the design of medication relatedapplications were used to develop an initial prototype that
addressed the challenges and barriers identiﬁed. After obtaining
Institutional Review Board approval, an exploratory study was
conducted to conceptualize and design technology to assist older
adults in the OTC consumer decision-making process. A combina-
tion of reviews with HCI researchers and sessions with older adults
were used to identify tasks, information needs, features, function-
ality and aspects of the look-and-feel that were useful to the task of
OTC consumer decision-making (see Fig. 1). Two review sessions
were held with HCI researchers to discuss the preliminary
prototypes, evaluate the designs based on their knowledge of
design principles and design for older adults, and discuss how well
the prototype might facilitate the task of OTC consumer
decision-making. In addition, older adults were engaged in design
sessions to better understand features and functionality that might
be useful in the task of OTC consumer decision-making as well as
to provide any feedback or concerns with usability or ease of use.3. Review sessions
Two researchers met over the period of 2.5 months to brain-
storm preliminary prototype ideas and iteratively evaluate the
potential for the prototype to facilitate the task of OTC consumer
decision-making for older adults. For the initial prototypes, the
researchers’ goals were to explore different ways to address the
challenges identiﬁed in literature and in the preliminary study
including: support for consumer friendly presentation of medical
terminology, tailored design for older adults, and making the tech-
nology easily accessible by those with diverse computing experi-
ences. Nielsen’s Heuristics were used to guide reviews of the
prototypes [33]. Prototypes that were reviewed ranged from
low-ﬁdelity (paper-based mock-ups designed in PowerPoint) to
medium-ﬁdelity (PowerPoint decks that included simulated inter-
actions). Overall, the researchers aimed to design an interface that
could impact older adults’ ‘‘attitudes and behaviors’’ toward OTC
decision-making. Prior research indicates that many times con-
sumers are unaware of OTC medication risks and may need sup-
port when navigating OTC medication information [11,26].
Persuasive tools are ‘‘interactive products designed to change atti-
tudes or behaviors’’ [13]. This implies that a persuasive design may
be useful for addressing some of the challenges and barriers faced
by older adults when selecting OTC medication. The preliminary
design therefore included aspects of persuasive technology design
that could potentially address those challenges.
The preliminary prototypes of the system were designed to
include aspects of microsuasion [13]. Systems that include micro-
suasion do not have the overall intent to persuade but instead
incorporate persuasive elements to achieve some other goal.
Because the overall intent of the system was to assist older adults
in OTC decision-making, three persuasive tools (Reduction,
Tunneling, and Tailoring) were integrated to the design of the sys-
tem (See Fig. 2).3.1. Review session 1
The ﬁrst two prototypes were designed as search interfaces that
supplemented the information provided on the OTC medication
label. After typing in a medication name and searching for a med-
ication the user would be presented with a tabbed interface that
provided information about the medication (see Fig. 3). The second
prototype allowed users to enter information about their medica-
tion and chronic illnesses and the system would then customize
information based on their input. In the second prototype, users
would also be presented with a code on their ﬁrst use so that they
Fig. 1. Iterative design process.
Fig. 2. Persuasive tools used in prototype design.
Fig. 3. Initial prototypes.
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system.
Both prototypes were designed to be presented on a kiosk and
allow for touch input and audio output. Two HCI researchers eval-
uated the initial prototypes for their potential for assisting older
adults with OTC consumer decision-making. Although the proto-
types addressed several of the initial design goals, researchers
identiﬁed several usability concerns in the review.3.2. Review Session I results
First, there was concern that the text-based input method did
not provide for ﬂexible input, would require users to know how
to spell their medication names, and would increase task
completion time. Second, the way that medication information
was presented needed improvement to support a more minimalist
and persuasive design, providing users with more guidance and
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and intelligence was a special concern in the conceptualization of
the initial prototype. One mockup did not ask for any personal data
while the other provided the option to include personal data.
Researchers agreed that a more seamless approach to providing
customization while considering privacy was needed.
3.3. Review session 2
Following the ﬁrst review session, two prototypes were
designed to address the concerns identiﬁed (see Fig. 4). Both were
designed as multimodal systems that allow touch input and pro-
vided both visual and audio output. The ﬁrst version was designed
as a recommender system. Users could choose conditions they had
and/or medication they were taking and the system would provide
a recommendation of whether the medication was appropriate. In
addition, alternative designs were created that included an option
to view other medication that may be appropriate. The second ver-
sion of the prototype was designed to provide the user with infor-
mation only. In this version, the system would alert users of any
medical conditions and/or medication that might interact with
the medication and provide no information of whether the medica-
tion was appropriate.
To address the concerns identiﬁed in the ﬁrst round of review, a
barcode scanner was added, which was informed by prior work, to
eliminate the need for text-based input [39]. To reduce the amount
of information presented to the user, information about the
medication was limited to beneﬁts and potential interactions with
medical conditions and other medication. The interface was
re-designed to be more persuasive and to guide users through
the process while highlighting information identiﬁed in a prelimi-
nary study by participants as important to the OTC
decision-making task. To address the trade-offs between
privacy and intelligence, the new design included a degree ofFig. 4. Recommendercustomization that did not require users to input information
about medication and illnesses directly. Instead, the system sug-
gested potential illness and medication interactions with the med-
ication being considered. Users could then select any of the options
that applied to their case and the system would use this informa-
tion to provide recommendations about whether or not the medi-
cation may be safe for them to take.
3.4. Review session 2 results
A review of the updated prototypes yielded several additional
usability concerns. First, one reviewer mentioned that the design
of the checkboxes were not consistent with standards from his
experience with designing touch-based systems. The design was
therefore updated to remove obvious checkboxes (see Fig. 5).
Second, there was concern about the language and terminology
used to describe the risks and beneﬁts of the medication and
how that information should be presented. Reviewers were con-
cerned that this information may not transfer in a real-world set-
ting. Because of this, the prototype was updated to include links
to consumer-friendly language instead. This approach allowed us
to provide the option of consumer-friendly language without alter-
ing the original information. It was also decided that ‘‘I AM NOT
SURE’’ should be included as an option in the list of medication
and conditions presented to the user to provide more ﬂexibility
and provide the user with an outlet if none apply. Similarly, a
‘‘Back’’ and ‘‘Cancel’’ button was added to each screen to allow
the users more control over their navigation. Finally, red and green
coloring was added to the ﬁnal screen to make the notiﬁcation of
the system’s recommendation more visible. Red suggested a poten-
tial interaction may occur while green suggested no interactions
were found. There was also some concern with links being dis-
played on a button. However, it was decided to test the concept
with users to get feedback.system prototype.
Fig. 5. Updated prototype.
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cern about the amount of medication information included in the
prototype and how well it supported a minimalist design.
Therefore, based on a prior study, the prototype was updated to
include all information included on the Drug Facts label, but in
chunks based on topic (i.e. Inactive Ingredients, Purpose) instead
of all at once.4. Semi-structured interviews
Following the expert review, the preliminary prototype was
evaluated with older adults to obtain additional feedback about
its usability and learn about features that were useful to assist with
the OTC consumer decision-making task. Because the focus was to
conceptualize a consumer-decision making tool that could be used
independently by an older adult consumer, participants were pur-
posefully recruited to meet several criteria. Participants were
required to be at least 65 years of age, purchase or select their
own OTCmedication, and have purchased at least one OTCmedica-
tion within the past year.4.1. Setting and participants
Seven older adults volunteered to participate (female = 3,
male = 4). Participants’ ages ranged from 65 to 75 (mean = 70,
S.D. = 3.1). Three participants were Caucasian and four participants
were African–American. All but two participants (n = 5) had at
least some college education and all but one participant (n = 6)
was retired. Most participants reported taking at least one OTC
medication per week. One participant took OTC medication every
3–4 months. IRB approval was obtained before the study began
and participants provided consent to participate before eachsession. Individual sessions with older adults were conducted
on-site at two locations that serve older adults.
4.2. Materials
During a session, the participant was presented with a mixture
of low-ﬁdelity and medium-ﬁdelity paper-based prototypes of an
OTC consumer decision-making technology. Participants were then
provided with a verbal scenario and were asked to interact with
the prototype and walk through an OTC decision-making task.
The scenario involved a ﬁctional adult that was 65 years old that
had a list of conditions/diseases and medication. The scenario
was provided to give participants more context of the problem
being studied and also to provide a basis for their initial walk-
through of the system. The prototype was presented to partici-
pants on an iPad device. The prototype mimicked a partially
functioning touch-screen interface and simulated text-to-speech
by speaking the words presented on the screen. It guided
participants through the task of navigating the OTC medication
information (see Fig. 5). In addition, participants were presented
with low-ﬁdelity prototypes after they interacted with the
medium-ﬁdelity prototype. The low-ﬁdelity prototypes were
designed to look similar to the medium-ﬁdelity prototype’s inter-
face, but were printed in color and presented to participants
instead of being presented on the iPad. The low-ﬁdelity prototypes
represented alternative functionality that the medium-ﬁdelity pro-
totype might have.
4.3. Interview protocol
Once the participants ﬁnished interacting with the prototype,
they were asked a series of questions in the form of a
semi-structured interview. Interview questions centered on
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prototype; motivations for use; ease of use; language; guidance;
trust; and amount of information provided. The primary role of
the prototype was to act as a technology probe [16] and discussion
point to elicit conversation on the usefulness of the features during
the interview session. In addition, several alternative paper-based
mock-ups (i.e. low-ﬁdelity prototypes) were used in the interview
to encourage discussion of features that were not included in the
medium-ﬁdelity prototype, but were being considered for inclu-
sion by the researchers. The purpose of the alternative mock-ups
was to elicit discussion of additional features participants felt were
needed but not included in the current design or features that
could be removed. Therefore, the design sessions were not iterative
and each participant viewed the same prototype throughout the
duration of the study. In addition to responses to interview ques-
tions, feedback was also collected through observation and direct
response from participants on any usability and design concerns.4.4. Semi-structured interview results
4.4.1. Usability and design concerns
A total of nine usability issues were identiﬁed during the study
(see Table 1). Of the nine usability issues found, three were identi-
ﬁed by over half of the participants in the study. A usability issue
was deﬁned as anything that prevented the user from ﬁnishing
the task at hand [42]. This included anything that caused confusion
such as not seeing something that should be noticed, not under-
standing the navigation, and/or misinterpreting content. During
the study, participants were observed and the researcher recorded
potential usability issues. The researcher considered both verbal
and non-verbal expressions made by the participant when inter-
acting with the system that might indicate a usability issues. In
addition, usability issues described in the interview transcripts
were identiﬁed, analyzed, and coded.
Each of the nine usability issues were rated based on severity to
the overall design of the system. A high severity task is any issue
that leads to task failure [42]. Two issues were rated as high sever-
ity (1) It was not clear how to move to the next step in the system
and (2) It was not clear how to begin using the system. Although
these tasks may not lead to task failure, they may deter use of
the system or prevent users from completing task. Two tasks were
rated as medium severity. Medium severity tasks contribute to
task failure but do not directly prevent task failure [42]. All other
tasks were rated as low severity due to the number of participantsTable 1
Usability concerns.
# Description Unique
instances
Participants
affected
Severity
rating
1 Inactive ingredient information is
not necessary and should be
optional
4 2 Low
2 Navigation is not clear 9 4 High
3 There is no easy exit and the user
must ﬁnish all steps before
getting to the ﬁnal screen
2 2 Low
4 It is not clear how to get started 6 6 High
5 It is difﬁcult to select buttons that
list conditions and medication
6 3 Medium
6 Links to additional information
about medical terms are not
noticeable
6 5 Low
7 There is no option to turn off
speech
2 2 Low
8 Voice user interface is inaudible
even at highest volume setting
5 5 Medium
9 It is not clear that speech
recognition is not available
2 1 Lowthat identiﬁed the issue and/or its overall impact on the system
design.
Typically, ﬁve participants are recommended for usability test-
ing as nearly 80% of usability issues are thought to be observed
with the ﬁrst ﬁve participants [23,35]. Because, this is an early
stage usability test on a novel system design, seven participants
were recruited to help to reﬁne the design. Data gathered from
the seven participants reveal that the overall average proportion
is 0.49, which is the overall probability rate for the test (see
Table 2). The probability of detection is therefore 0.991. This sug-
gests that 99.1% of the usability issues found would be identiﬁed
with a sample of seven users (see Fig. 6).
4.4.2. Design implications
Interviews with older adults continued until no new insights
were gained. Participants’ interview responses were transcribed,
coded, and analyzed for recurring themes. One researcher analyzed
data initially to create a coding guide. Afterward, two researchers
met several times to discuss the guide and update it based on their
independent views of the data. The researchers then used the guide
to code the interview transcripts. NVivo 10 was used for ﬁnal cod-
ing and analysis and a coding comparison of all themes yielded an
average percent agreement of 99.176% and an average Kappa of
.851746 indicating excellent agreement. Five design considerations
were identiﬁed that represented features and functionality partic-
ipants found useful to help with the tasks of selecting appropriate
OTC medication.
4.4.2.1. Guidance. The prototype was designed to guide participants
through the process of selecting an OTC medication (see Fig. 5).
Varying information about the medication was highlighted at each
step of the process; participants provided input about conditions
and medication, and at the end, a decision was provided stating
whether or not the medication is appropriate. The information
highlighted in the prototype was based on the Federal Drug
Administration Drug Facts guidelines and was presented in chunks
based on the grouping presented in the guidelines. The interface
was designed purposefully to provide tunneling (guided persua-
sion) in order to motivate consumers to use OTC medication infor-
mation in the OTC decision-making task. When asked to discuss
the wizard-like interface, all participants in the study (n = 7)
expressed a favorable impression of the wizard concept. For exam-
ple, Participant 1 commented on the usefulness of the approach: ‘‘I
like the wizard approach, stepping people through and going down dif-
ferent paths depending on the response’’ (P1)
In short, participants discussed that having the system guide
them through the process of selecting a medication was something
they viewed as beneﬁcial for the prototype and useful for helping
with an OTC decision-making task.
4.4.2.2. Personalization, tailoring, and decision support. Although the
prototype was tailored to the design needs of older adults, the orig-
inal prototype provided a limited degree of personalization.
Participants were presented with conditions and medication that
might potentially conﬂict with the OTC medication and were asked
to select any that apply. Conditions and medication were taken
directly from the drug fact label and grouped accordingly. While
most participants liked this approach, it was designed only to act
as a data-gathering step for the prototype’s decision support algo-
rithm. However, some participants suggested that the system
should have an option for providing a higher degree of customiza-
tion at the individual level. Participant 4 stated:
‘‘My wife has a thing called Sweet’s syndrome. She can’t take any
steroids. I believe one of the things in here was some sort of steroid,
as an inactive ingredient. One of the things . . . you need to have a
Table 2
Average proportion of usability issues found.
Participant Issue 1 Issue 2 Issue 3 Issue 4 Issue 5 Issue 6 Issue 7 Issue 8 Issue 9 Proportion
P1 X X X 0.33
P2 X X X X X X 0.67
P3 X 0.11
P4 X X X 0.33
P5 X X X X X X 0.67
P6 X X X X X X 0.67
P7 X X X X X X 0.67
Proportion 0.57 0.57 0.29 0.86 0.29 0.72 0.29 0.72 0.14 0.49
Fig. 6. Probability of detection.
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that they can weed out the medications that they deﬁnitely can’t
take.’’ (P4)
Similarly, when asked if she felt the prototype provided enough
information, another participant stated: ‘‘It didn’t say this medicine
may affect people who have diabetes . . . It should be listed if it’s going
to interfere with people with diabetes I think it should be listed.’’ (P3)
The condition mentioned by Participant 4 was not included in
the warnings section of the medication box and therefore was
not included in the prototype. Therefore, it may be beneﬁcial to
look beyond the information on the label to include other informa-
tion such as potential condition/ingredient interactions that may
not be speciﬁcally stated in the warnings section. This functionality
suggests another degree of reasoning and information retrieval
that was not provided by the prototype at the time of this study.
Participants also discussed having the ability to input information
about medication or conditions before using the systemwhich sug-
gests the need to further explore ways to include users’ personal
information without sacriﬁcing privacy.
4.4.2.3. Trust and system recommendation. Alternative screen
mock-ups were included to elicit discussions about others ways a
system could support older adults in the OTC decision-making
task. In comparison with the high-ﬁdelity prototype in which the
participant ﬁrst interacted, the alternative mockup did not prompt
the user to select any medications or conditions they had or were
taking; and did not provide a recommendation of whether the
medication was appropriate.
The alternative prototype was included because researchers
were uncertain of whether or not users would trust a recommen-
dation provided by a machine or ﬁnd it useful. Researchers wanted
to explore this idea more with older adults. Trust is a well-known
concern when designing persuasive technology [13]. To the sur-
prise of the researchers, all participants (n = 7) indicated that a sys-
tem that provided a recommendation would be more beneﬁcial to
them than a system that provided information only. When asked,
all participants (n = 7) indicated they would be comfortable acting
on a recommendation made by the system and preferred theprototype that made a recommendation over the prototype that
only provided information. On the other hand, most participants
also discussed the need for stronger disclaimers and language to
ensure consumers would be aware that the system did not replace
the advice of a medical professional.
Participants also talked about the beneﬁt of having the system
provide alternative medication options if the medication they
selected was not appropriate. This feature was provided as an
alternative to receiving a message stating that the medication is
not appropriate. All participants (n = 7) preferred to receive recom-
mendations of other medication that might be appropriate as
opposed to a ‘‘not appropriate’’ message only.
4.4.2.4. Consumer-friendly health language. The prototype provided
consumer-friendly explanations of different medical terms with
the goal of helping participants better understand the overall risks
or warnings being presented to them. This was an attempt to sim-
plify the medication information and motivate consumers to com-
plete the task. Although most participants did not notice this
option when interacting with the prototype, all participants later
indicated that the consumer-friendly explanations of medication
terms would be beneﬁcial to helping them better understand the
information if they needed it. Participant 4 stated: ‘‘I think people
would know I’m taking something for anxiety or I’m taking something
for depression. They may not even remember the name of it. I don’t
pay attention. I take blood pressure medication and cholesterol medi-
cation. When I ﬁll out a form what medication I’m on, I can’t remem-
ber.’’ (P4)
Another participant discussed his frustration with medication
information and why he felt language support was useful: ‘‘It’s
intimidating because it’s so much information and what am I supposed
to do with it? Am I supposed to understand it? Am I supposed to rec-
ognize those chemicals? It’s a bit intimidating.’’ (P6)
Although most participants indicated that they found the lan-
guage support useful, the interview data also reveals that more
attention should be paid to how consumer-friendly language can
best assist in the task at hand. For example, most participants
did not think that the inactive ingredients needed explanation
although they too can include complex medical terms. On the
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alerted of potential interactions with ingredients. Most partici-
pants indicated that the explanations provided about the medica-
tion in the warnings section were useful, but data revealed that
the concept of providing consumer-friendly language should be
further studied to understand what information should be
included, the language that should be used, and how the informa-
tion should be presented.
4.4.2.5. Support for sharing. Initially, the prototype presented to the
participants did not include any options for sharing information
about an OTC medication selection or the results obtained from
the system. However, interview data revealed that options for
sharing the information provided by the system might not only
be helpful for making an independent decision, but also for initiat-
ing discussions with the pharmacist or doctor. The words doctor,
pharmacist, drugstore man, and druggist (pharmacist) were men-
tioned 34 times by participants over all interview data. Six of the
seven participants discussed that they may talk with a doctor or
pharmacist in addition to using the system, if they had follow-up
questions or were still unsure about a medication. Participant 5
stated: ‘‘I mean, you’re always going to need the pharmacist’s help,
. . . but this would help you. . . that would save . . . you can ﬁnd a lot
of stuff yourself’’ (P5).
The other ﬁve participants made similar comments in their
interview. This suggests that the system was viewed as designed,
a supplement (not a replacement) to the doctor or pharmacist.
However, the data also reveals the importance of providing users
with information that can assist in their conversations with the
doctor and/or pharmacist. This feature was not considered as a pri-
mary concern in the preliminary design. However, interviews sug-
gest that providing options for sharing that support
communication between the consumer, doctor and/or pharmacist
may also be beneﬁcial to assisting in the decision-making process.
Keeping the consumer informed helps them to become more
knowledgeable and aware of their own medication management
practices. This leads to a more informed consumer that comes to
the conversation with a health professional more prepared to par-
ticipate in the discussion. Sharing also provides the doctor with
information on his or her patient’s medication practices at home
and helps to facilitate a conversation in which the consumer
already has some knowledge or stake.Fig. 7. Evolution of the technology support mechanis5. Discussion
Including older adults in the early stages of design for this novel
technology helped to reﬁne the initial prototype design and model
of how technology can be used to support older adults in the OTC
decision-making task (see Fig. 7). Using an iterative user-centered
process in the formative stages of design was useful to understand
aspects of the technology design that are useful to older adults
when making decisions about OTC medication. Using this process,
technology support mechanisms included in the initial model were
also revised based on the results. The iterative design sessions
helped the researchers to understand the problem space, which
helped to conceptualize a system that could assist with the OTC
decision-making task.
Initially, the prototype included four types of technology sup-
port mechanisms. The design included the concept of tunneling
or guiding the user through a deﬁned set of steps. This process
helped to highlight information that was important for older adults
to consider when selecting an OTC medication. The prototype was
designed using guidelines (e.g. font-size) that are suited for the
older population. Further, the design included consumer-friendly
health language provided through automatic generated explana-
tions of health terms and decision support of whether or not a
medication was appropriate given a user’s input. Obtaining feed-
back from reviewers and older adults helped to reﬁne this model
by discovering other ways technology could support the OTC
decision-making process.
Data revealed that technology could also be helpful by provid-
ing the user with system recommendations through information
ﬁltering of user data to predict other medication that may be
appropriate. Users expressed that they would also be interested
in having more control over the system’s input and output. Some
participants expressed the need for a more individualized level of
personalization by allowing input of information about chronic ill-
nesses or medication to help reﬁne the decision support. Similarly,
some participants also discussed going beyond the information on
the box to include other information about potential interactions
that might be beneﬁcial to the decision-making process. This also
included a suggestion for including an additional level of reasoning
to identify potential adverse reactions to the medication ingredi-
ents. Lastly, because nearly all users stressed the importance of
having the option to keep the pharmacist, nurse, or doctorm model for older adults’ OTC decision making.
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model to not only support consumers in the decision-making pro-
cess, but also to help facilitate discussions about potential OTC
medication with persons of their choosing. In addition, although
the prototype was used as a probe to spur discussion about the
usefulness of the features, the usability concerns identiﬁed high-
light additional areas where the design of the existing prototype
system can be improved and provide opportunities to explore ways
to address these concerns.
Some features such as system recommendations were included
as an option in the ﬁnal probe used in sessions with older adults
and were conﬁrmed as useful in discussions with participants
(see Fig. 5). However personalization and user-centered informa-
tion sharing were not included in the updated prototype design.
Therefore, options for users to enter health-related information
are currently being added to the design. Similarly, optional features
for sharing information are also being included in the updated
design. Although the ﬁndings suggest that the features provided
in the probe were useful to older adults, the most recent prototype
design does not allow for the desired levels of personalization indi-
cated by participants of the study and only provides one option for
navigating through the OTC medication information. Therefore a
more ﬂexible design is needed to accommodate older adults with
different information needs, personalization, and navigation pref-
erences. In addition, further research is needed to understand
how to provide consumer-friendly health information in the con-
text of a consumer health application. The results from this study
can be used to help designers think about the types of technology
support older adults ﬁnd useful when selecting appropriate OTC
medication. However, more research will be needed to understand
how to accommodate these mechanisms in the design of a con-
sumer health application.6. Conclusions and future work
The goal of this study was to understand and explore technol-
ogy features that may be beneﬁcial to assisting older adults in this
task. The results of this study provide discussion of the process of
designing an interface that supports older adults in OTC medica-
tion decision-making. Because no such technology currently exists
for assisting older adults, it was important to gain feedback early in
the design to understand what features and functionalities pro-
vided by technology would be most supportive in this task.
Additionally, because of the exploratory nature of the study, impli-
cations for design were not only identiﬁed early, but the process
helped the researchers to conceptualize the technology before con-
siderable time was spent on implementing technology that may
not be useful to the population in question.
Through user sessions with seven older adults, existing usabil-
ity concerns were identiﬁed in the initial prototype design. Nine
usability issues were identiﬁed by seven users in the current
design representing a probability of detection of .917. Therefore,
99.1% of usability issues would be identiﬁed with the seven users
included in the study. In addition, qualitative data was collected
to identify features and functionality that technology can provide
to support older adults in the OTC decision-making process. Five
design considerations were identiﬁed for technology to assist older
adults in the task of selecting appropriate OTC medication.
The design considerations, feedback, and model identiﬁed in
this study will be used to inform the design of current and future
technologies developed to help with OTC decision-making tasks.
The data from the reviews and interviews with older adults
revealed several opportunities for technology to support older
adults in the OTC decision-making task. Results suggest that older
adults found features of the prototype supportive for assisting withOTC decision-making, however results also indicate the need for a
more ﬂexible design to accommodate individuals with different
information needs, personalization preferences, and navigation
preferences. Because of this, the researchers are currently looking
at ways to redesign the prototype to provide a ﬂexible design for
users with varying needs while including the technology support
mechanisms that were found useful. The new model will be used
to guide design changes in the current prototype interface and to
guide the implementation and study of other technology
support mechanisms (e.g. decision support algorithm, health
text-simpliﬁcation approach) that will be included in the system
implementation. Although many of the features identiﬁed relate
speciﬁcally to the task of selecting appropriate OTC medication,
some considerations may be useful to the design of other
consumer-decision making applications for older adults and other
user populations.7. Limitations
The study included several rounds of review and interviews
with seven participants (age 65+), which is more than the recom-
mended number of participants for usability testing [23,35]. A
‘‘rich, thick’’ or detailed description of the study and its partici-
pants is utilized to support external validity by providing a frame-
work for transferability [10]. However, although user sessions were
conducted until no new data emerged from the accompanying
interview with participants, the study may be limited by number
of people interviewed. Therefore, additional studies will be per-
formed to determine if the ﬁndings of this study can be generalized
to a larger population. In addition, although the prototype helped
to elicit feedback about technology support mechanisms useful
to older adults for OTC decision-making, there is no evidence to
ensure that the overall design of the current prototype is a useful
approach for assisting with OTC decision-making. Further research
focused on evaluating the prototype design will be needed to val-
idate the prototype’s usefulness in the OTC decision-making
process.Conﬂict of Interest
Author states that there is no ‘Conﬂict of Interest’.
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